This is a preview of subscription content, log in via an institution to check access.
Reference
Cho A, et al. Real-world experience of olaparib as maintenance therapy in BRCA-mutated recurrent ovarian cancer. Archives of Gynecology and Obstetrics 304: 1055-1063, No. 4, Oct 2021. Available from: URL: http://doi.org/10.1007/s00404-021-06013-x
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1881, 28 (2021). https://doi.org/10.1007/s40278-021-05237-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-05237-0